Searching News Database: AMO Pharma
HSMN NewsFeed - 30 May 2017
AMO Pharma Announces FDA Fast Track Designation For AMO-02 For Treatment Of Congenital Myotonic Dystrophy
AMO Pharma Announces FDA Fast Track Designation For AMO-02 For Treatment Of Congenital Myotonic Dystrophy
HSMN NewsFeed - 3 Jul 2007
Azur Pharma Announces the Acquisition of FazaClo for $42 Million Plus Contingent Milestones
Azur Pharma Announces the Acquisition of FazaClo for $42 Million Plus Contingent Milestones
HSMN NewsFeed - 3 Jul 2007
AVANIR Pharmaceuticals Announces Sale of FazaClo to Fund Continued Development of Zenvia
AVANIR Pharmaceuticals Announces Sale of FazaClo to Fund Continued Development of Zenvia
HSMN NewsFeed - 3 Apr 2007
Amarin Appoints Paul F. Duffy to New Position of President - U.S. Commercial Operations
Amarin Appoints Paul F. Duffy to New Position of President - U.S. Commercial Operations
HSMN NewsFeed - 23 May 2006
AVANIR Announces the Intended Acquisition of a Private Specialty Pharmaceutical Company
AVANIR Announces the Intended Acquisition of a Private Specialty Pharmaceutical Company
Additional items found! 3
Members Archive contains
3 additional stories matching:
AMO Pharma
(Password required)
AMO Pharma
(Password required)
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!